Home > Research > Publications & Outputs > Selecting Core Outcomes for Randomised Effectiv...

Links

Text available via DOI:

View graph of relations

Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set

Research output: Contribution to journalJournal articlepeer-review

Published

Standard

Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT) : study protocol for the development of a core outcome set. / SCORE-IT study team.

In: Trials, Vol. 427, 427, 07.08.2018.

Research output: Contribution to journalJournal articlepeer-review

Harvard

APA

Vancouver

Author

Bibtex

@article{b6fb9402aff94156ae51bd027391c029,
title = "Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set",
abstract = "BACKGROUND:Type 2 diabetes is characterised by abnormal glucose metabolism, and treatment is aimed at normalising glycaemia. Outcomes measured in clinical trials should be meaningful to patients, health care professionals and researchers, yet there is heterogeneity in the outcomes used across trials of glucose-lowering interventions. This inconsistency affects the ability to compare findings and may mean that the results have little importance to health care professionals and the patients for whom they care. The SCORE-IT study aims to develop a core outcome set (COS) for use in all trials of glucose-lowering interventions for people with type 2 diabetes. METHODS/DESIGN:This study will involve three key stages in the development of a COS: (1) A list of outcomes will be identified from multiple sources, specifically registered clinical trials, online patient resources, the qualitative literature and landmark studies identified by a Study Steering Committee. (2) The list of outcomes will be scored by multiple stakeholder groups in a two-round online international Delphi survey. (3) The results of the online Delphi will be summarised and discussed at a face-to-face consensus meeting with representation from all stakeholder groups. DISCUSSION:The SCORE-IT study aims to develop an internationally relevant set of core outcomes for use in future trials of glucose-lowering interventions for type 2 diabetes. The use of a COS will improve the consistency of outcomes, allowing results of studies to be compared and combined and for new effective treatments to made available more quickly. TRIAL REGISTRATION:The COS study, of which this is a part, is registered in the Core Outcome Measures in Effectiveness Trials (COMET) database, http://www.comet-initiative.org/studies/details/956 . Registered January 2017.",
author = "{SCORE-IT study team} and Harman, {Nicola L.} and John Wilding and Dave Curry and James Harris and Jennifer Logue and Pemberton, {R. John} and Leigh Perreault and Gareth Thompson and Sean Tunis and Williamson, {Paula R.}",
year = "2018",
month = aug,
day = "7",
doi = "10.1186/s13063-018-2805-2",
language = "English",
volume = "427",
journal = "Trials",
issn = "1745-6215",
publisher = "BIOMED CENTRAL LTD",

}

RIS

TY - JOUR

T1 - Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT)

T2 - study protocol for the development of a core outcome set

AU - SCORE-IT study team

AU - Harman, Nicola L.

AU - Wilding, John

AU - Curry, Dave

AU - Harris, James

AU - Logue, Jennifer

AU - Pemberton, R. John

AU - Perreault, Leigh

AU - Thompson, Gareth

AU - Tunis, Sean

AU - Williamson, Paula R.

PY - 2018/8/7

Y1 - 2018/8/7

N2 - BACKGROUND:Type 2 diabetes is characterised by abnormal glucose metabolism, and treatment is aimed at normalising glycaemia. Outcomes measured in clinical trials should be meaningful to patients, health care professionals and researchers, yet there is heterogeneity in the outcomes used across trials of glucose-lowering interventions. This inconsistency affects the ability to compare findings and may mean that the results have little importance to health care professionals and the patients for whom they care. The SCORE-IT study aims to develop a core outcome set (COS) for use in all trials of glucose-lowering interventions for people with type 2 diabetes. METHODS/DESIGN:This study will involve three key stages in the development of a COS: (1) A list of outcomes will be identified from multiple sources, specifically registered clinical trials, online patient resources, the qualitative literature and landmark studies identified by a Study Steering Committee. (2) The list of outcomes will be scored by multiple stakeholder groups in a two-round online international Delphi survey. (3) The results of the online Delphi will be summarised and discussed at a face-to-face consensus meeting with representation from all stakeholder groups. DISCUSSION:The SCORE-IT study aims to develop an internationally relevant set of core outcomes for use in future trials of glucose-lowering interventions for type 2 diabetes. The use of a COS will improve the consistency of outcomes, allowing results of studies to be compared and combined and for new effective treatments to made available more quickly. TRIAL REGISTRATION:The COS study, of which this is a part, is registered in the Core Outcome Measures in Effectiveness Trials (COMET) database, http://www.comet-initiative.org/studies/details/956 . Registered January 2017.

AB - BACKGROUND:Type 2 diabetes is characterised by abnormal glucose metabolism, and treatment is aimed at normalising glycaemia. Outcomes measured in clinical trials should be meaningful to patients, health care professionals and researchers, yet there is heterogeneity in the outcomes used across trials of glucose-lowering interventions. This inconsistency affects the ability to compare findings and may mean that the results have little importance to health care professionals and the patients for whom they care. The SCORE-IT study aims to develop a core outcome set (COS) for use in all trials of glucose-lowering interventions for people with type 2 diabetes. METHODS/DESIGN:This study will involve three key stages in the development of a COS: (1) A list of outcomes will be identified from multiple sources, specifically registered clinical trials, online patient resources, the qualitative literature and landmark studies identified by a Study Steering Committee. (2) The list of outcomes will be scored by multiple stakeholder groups in a two-round online international Delphi survey. (3) The results of the online Delphi will be summarised and discussed at a face-to-face consensus meeting with representation from all stakeholder groups. DISCUSSION:The SCORE-IT study aims to develop an internationally relevant set of core outcomes for use in future trials of glucose-lowering interventions for type 2 diabetes. The use of a COS will improve the consistency of outcomes, allowing results of studies to be compared and combined and for new effective treatments to made available more quickly. TRIAL REGISTRATION:The COS study, of which this is a part, is registered in the Core Outcome Measures in Effectiveness Trials (COMET) database, http://www.comet-initiative.org/studies/details/956 . Registered January 2017.

UR - http://europepmc.org/articles/PMC6081933

U2 - 10.1186/s13063-018-2805-2

DO - 10.1186/s13063-018-2805-2

M3 - Journal article

C2 - 30086771

VL - 427

JO - Trials

JF - Trials

SN - 1745-6215

M1 - 427

ER -